Funded Tech Companies
AdvanCell
Researching who provided funding to AdvanCell? Morningside Group joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
AdvanCell
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Level 7, Macquarie House, 167 Macquarie St,
Sydney, NSW, 2000
AU
Sydney, NSW, 2000
AU
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
AdvanCell is a radiopharmaceutical company developing next-generation cancer treatments. AdvanCell's targeted alpha therapies are powered by a platform technology -- a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy -- the reliable and scalable supply of isotope.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/24/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Bill Ferris
Chief Executive Officer
Andrew Adamovich
Chief Technical Officer
Simon Puttick
Company Investors
- Morningside Group (Anthony Aiudi)
Browse more funded tech companies:
AdvancedMD Software | AdvancePath
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs